IVAN F. DUFF, M.D.; JOHN R. GAMBLE, M.D.; PARK W. WILLIS III, M.D.; PAUL E. HODGSON, M.D.; WILLIAM S. WILSON, M.D.; JOSIAH A. POLHEMUS, M.D.
The decision to administer anticoagulant drugs should imply familiarity with the indisputable complication of hemorrhage which they evoke. This report is concerned with factors which are important in the control of excessive effect by these potent drugs.
A few years ago selection of an anticoagulant was not a problem, for the choice was limited to Dicumarol or heparin. In the search for more satisfactory preparations several derivatives have become available, and their number is now sufficiently large to be confusing. Pertinent summaries are to be found elsewhere1-5 regarding the details of administration and
DUFF IF, GAMBLE JR, WILLIS PW, HODGSON PE, WILSON WS, POLHEMUS JA. THE CONTROL OF EXCESSIVE EFFECT BY ANTICOAGULANTS(THE CONTROL OF EXCESSIVE EFFECT BY ANTICOAGULANTS*†)(THE CONTROL OF EXCESSIVE EFFECT BY ANTICOAGULANTS*†). Ann Intern Med. 1955;43:955–978. doi: 10.7326/0003-4819-43-5-955
Download citation file:
Published: Ann Intern Med. 1955;43(5):955-978.
Acute Coronary Syndromes, Cardiology, Coagulopathies, Coronary Heart Disease, Education and Training.
Results provided by:
Copyright © 2018 American College of Physicians. All Rights Reserved.
Print ISSN: 0003-4819 | Online ISSN: 1539-3704
Conditions of Use